P1355: VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) AFTER AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION (HCT): OUTCOMES OF DEFIBROTIDE-TREATED ADULT PATIENTS FROM THE DEFIFRANCE STUDY

MLA

M. Mohty, et al. “P1355: Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (Vod/Sos) After Autologous Hematopoietic Cell Transplantation (Hct): Outcomes of Defibrotide-Treated Adult Patients from the Defifrance Study.” HemaSphere, vol. 6, June 2022, pp. 1240–41. EBSCOhost, https://doi.org/10.1097/01.HS9.0000848284.17069.95.

APA

M. Mohty, I. Yakoub-Agha, J.-H. Dalle, M. Labopin, J. Cornillon, A. Huynh, T. Lamy, C. Soussain, K. Asubonteng, D. Gutierrez, & R. Peffault de Latour. (2022). P1355: Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (Vod/Sos) After Autologous Hematopoietic Cell Transplantation (Hct): Outcomes of Defibrotide-Treated Adult Patients from the Defifrance Study. HemaSphere, 6, 1240–1241. https://doi.org/10.1097/01.HS9.0000848284.17069.95

Chicago

M. Mohty, I. Yakoub-Agha, J.-H. Dalle, M. Labopin, J. Cornillon, A. Huynh, T. Lamy, et al. 2022. “P1355: Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (Vod/Sos) After Autologous Hematopoietic Cell Transplantation (Hct): Outcomes of Defibrotide-Treated Adult Patients from the Defifrance Study.” HemaSphere 6 (June): 1240–41. doi:10.1097/01.HS9.0000848284.17069.95.